AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.
Business Model:
Revenue: $0
Employees: 1-10
Address: 22 Strathmore Road
City: Natick
State: MA
Zip: 01760
Country: US
AffyImmune Therapeutics is a biopharmaceutical company specializing in affinity tuned Chimeric Antigen Receptor (“CAR”) T cell therapy in solid tumors. The Company’s proprietary technology may significantly improve the existing CAR-T cell therapy by extending the target of CAR-T therapies to solid tumors using a novel molecule and tuning down the affinity from picomolar to micromolar level to lower the on-target off-tumor toxicity.
Contact Phone:
+16176991965
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2018 | Funding Round | $7.9M | 8/2018 | Funding Round | $1M | 10/2021 | Series A | 1 | $20M |
ORI Capital ORI Capital |
10/2021 | Series A | $30M |
ORI Capital |
11/2018 | Seed Round | $7.9M | 8/2018 | Seed Round | $1M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|